Paper6344896
Multicentre controlled trial of tienilic acid in hyperuricaemic, hypertensive subjects, with intensive monitoring of liver function.
Br J Clin Pharmacol, 1983. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Multicentre controlled trial of tienilic acid in hyperuricaemic, hypertensive subjects, with intensive monitoring of liver function. Papers, record 6344896. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6344896
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glycolates | Major topic |
| Hypertension | Major topic |
| Ticrynafen | Major topic |
| Uric Acid | Major topic |
| Adult | |
| Aged | |
| Body Weight | |
| Clinical Trials as Topic | |
| Creatinine | |
| Electrolytes | |
| Female | |
| Humans | |
| Liver Function Tests | |
| Male | |
| Middle Aged | |
| Proteinuria | |
| Urea |
Source PubMed
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 937359 | Renal transport of urate during diuretic-induced hypouricemia. | Am J Med | 1976 | https://conductscience.org/library/papers/937359 | PubMed |
| 2 | 913063 | Mechanisms of the uricosuric effect of the diuretic tienilic acid (Ticrynafen) in man. | Clin Sci Mol Med | 1977 | https://conductscience.org/library/papers/913063 | PubMed |
| 3 | 619301 | Metabolic effects in man of tienilic acid, a new diuretic with uricosuric properties. | Nephron | 1978 | https://conductscience.org/library/papers/619301 | PubMed |
| 4 | 630794 | Ticrynafen, a uricosuric antihypertensive diuretic. | Clin Pharmacol Ther | 1978 | https://conductscience.org/library/papers/630794 | PubMed |
| 5 | 648082 | Ticrynafen: kinetics, protein binding, and effects on serum and urinary uric acid. | Clin Pharmacol Ther | 1978 | https://conductscience.org/library/papers/648082 | PubMed |
| 6 | 348380 | Ticrynafen and hydrochlorothiazide in hypertension. | Clin Pharmacol Ther | 1978 | https://conductscience.org/library/papers/348380 | PubMed |
| 7 | 80525 | Comparison of tienilic acid with cyclopenthiazide in hyperuricaemic hypertensive patients. | Lancet | 1978 | https://conductscience.org/library/papers/80525 | PubMed |
| 8 | 359019 | A double-blind comparison of the effects of hydrochlorothiazide and tienylic acid (a diuretic with uricosuric properties) in hypertension. | Br J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/359019 | PubMed |
| 9 | 372609 | Ticrynafen and hydrochlorothiazide. A double-blind study of antihypertensive properties with an open crossover. | JAMA | 1979 | https://conductscience.org/library/papers/372609 | PubMed |
| 10 | 381954 | Renal function during therapy in patients with congestive cardiac failure. Ticrynafen vs. hydrochlorothiazide. | Nephron | 1979 | https://conductscience.org/library/papers/381954 | PubMed |
| 11 | 381955 | Comparison of ticrynafen and probenecid in patients with elevated uric acid levels. | Nephron | 1979 | https://conductscience.org/library/papers/381955 | PubMed |
| 12 | 381956 | Antihypertensive and hemodynamic effects of ticrynafen compared with hydrochlorothiazide. | Nephron | 1979 | https://conductscience.org/library/papers/381956 | PubMed |
| 13 | 471153 | Comparative effects of ticrynafen and hydrochlorothiazide on blood pressure, renal function, serum uric acid and electrolytes, and body fluid spaces in hypertensive man. | Nephron | 1979 | https://conductscience.org/library/papers/471153 | PubMed |
| 14 | 381957 | Renal function during ticrynafen therapy. | Nephron | 1979 | https://conductscience.org/library/papers/381957 | PubMed |
| 15 | 492241 | Acute arthralgia (gout?) after tricrynafen. | N Engl J Med | 1979 | https://conductscience.org/library/papers/492241 | PubMed |
| 16 | 492283 | Acute renal failure from ticrynafen. | N Engl J Med | 1979 | https://conductscience.org/library/papers/492283 | PubMed |
| 17 | 492285 | Acute renal failure from ticrynafen. | N Engl J Med | 1979 | https://conductscience.org/library/papers/492285 | PubMed |
| 18 | 7351817 | Adverse reactions associated with ticrynafen use. | JAMA | 1980 | https://conductscience.org/library/papers/7351817 | PubMed |
| 19 | 7351819 | Acute renal failure during treatment with ticrynafen. | JAMA | 1980 | https://conductscience.org/library/papers/7351819 | PubMed |
| 20 | 7351824 | Ticrynafen's withdrawal from the market. | JAMA | 1980 | https://conductscience.org/library/papers/7351824 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 3884320 | Diuretics. Clinical pharmacology and therapeutic use (Part II). | Drugs | 1985 | https://conductscience.org/library/papers/3884320 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Authors
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6344896
GET https://conductscience.org/api/papers/v1/6344896/references?page=2